Synopsys, Inc. $SNPS Stock Holdings Lifted by Stanley Laman Group Ltd.

Key Points

• Stanley Laman Group Ltd. increased its stake in Synopsys by 542.9%, buying an additional 10,874 shares to hold 12,877 shares worth about $6.35 million (its 22nd largest position).
• Synopsys beat quarterly EPS estimates ($2.90 vs. $2.79), reported $2.25 billion in revenue (up 37.8% YoY), and set FY 2026 EPS guidance of 14.32–14.40.
• CFO Shelagh Glaser sold 3,657 shares for roughly $1.69 million (insiders own 0.62%), while analysts rate the stock a Moderate Buy with an average price target of $562.13.

Stanley Laman Group Ltd. grew its position in Synopsys, Inc. (NASDAQ:SNPS - Free Report) by 542.9% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 12,877 shares of the semiconductor company's stock after purchasing an additional 10,874 shares during the period. Synopsys comprises about 0.9% of Stanley Laman Group Ltd.'s holdings, making the stock its 22nd largest position. Stanley Laman Group Ltd.'s holdings in Synopsys were worth $6,353,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Brighton Jones LLC raised its position in Synopsys by 5.7% during the fourth quarter. Brighton Jones LLC now owns 921 shares of the semiconductor company's stock valued at $447,000 after acquiring an additional 50 shares in the last quarter. Integrated Wealth Concepts LLC increased its stake in shares of Synopsys by 11.6% during the 1st quarter. Integrated Wealth Concepts LLC now owns 760 shares of the semiconductor company's stock worth $326,000 after purchasing an additional 79 shares during the last quarter. NewEdge Advisors LLC raised its holdings in shares of Synopsys by 15.1% during the 1st quarter. NewEdge Advisors LLC now owns 3,010 shares of the semiconductor company's stock valued at $1,291,000 after purchasing an additional 395 shares in the last quarter. Scientech Research LLC lifted its stake in shares of Synopsys by 6.9% in the 1st quarter. Scientech Research LLC now owns 1,689 shares of the semiconductor company's stock valued at $724,000 after purchasing an additional 109 shares during the last quarter. Finally, UniSuper Management Pty Ltd boosted its holdings in Synopsys by 2.9% in the first quarter. UniSuper Management Pty Ltd now owns 70,955 shares of the semiconductor company's stock worth $30,429,000 after purchasing an additional 2,002 shares in the last quarter. 85.47% of the stock is owned by hedge funds and other institutional investors.

Synopsys Stock Up 2.3%

Shares of SNPS stock opened at $480.42 on Monday. Synopsys, Inc. has a 12 month low of $365.74 and a 12 month high of $651.73. The company has a quick ratio of 1.52, a current ratio of 1.62 and a debt-to-equity ratio of 0.48. The firm has a market cap of $91.91 billion, a PE ratio of 60.13, a price-to-earnings-growth ratio of 4.00 and a beta of 1.12. The stock has a 50 day moving average of $439.30 and a 200-day moving average of $503.42.

Synopsys (NASDAQ:SNPS - Get Free Report) last announced its quarterly earnings data on Wednesday, December 10th. The semiconductor company reported $2.90 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.79 by $0.11. The business had revenue of $2.25 billion for the quarter, compared to the consensus estimate of $2.25 billion. Synopsys had a net margin of 18.89% and a return on equity of 7.89%. Synopsys's quarterly revenue was up 37.8% on a year-over-year basis. During the same quarter last year, the company posted $3.40 earnings per share. Synopsys has set its FY 2026 guidance at 14.320-14.400 EPS and its Q1 2026 guidance at 3.520-3.580 EPS. On average, equities analysts predict that Synopsys, Inc. will post 10.64 EPS for the current year.

Wall Street Analyst Weigh In

A number of analysts have weighed in on the company. Piper Sandler reduced their price target on Synopsys from $630.00 to $602.00 and set an "overweight" rating for the company in a research report on Thursday, December 11th. Robert W. Baird reissued a "neutral" rating and issued a $535.00 price objective (down from $670.00) on shares of Synopsys in a research note on Wednesday, September 10th. Rosenblatt Securities upgraded Synopsys from a "neutral" rating to a "buy" rating and reduced their target price for the stock from $605.00 to $560.00 in a report on Tuesday, December 9th. JPMorgan Chase & Co. increased their price target on Synopsys from $600.00 to $650.00 and gave the company an "overweight" rating in a report on Thursday, December 11th. Finally, Bank of America upgraded shares of Synopsys from an "underperform" rating to a "neutral" rating and reduced their price objective for the stock from $525.00 to $500.00 in a research note on Monday, December 8th. Eleven analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, the company presently has an average rating of "Moderate Buy" and an average price target of $562.13.

Insider Activity

In other news, CFO Shelagh Glaser sold 3,657 shares of the company's stock in a transaction dated Friday, December 19th. The shares were sold at an average price of $460.77, for a total transaction of $1,685,035.89. Following the completion of the transaction, the chief financial officer owned 17,842 shares of the company's stock, valued at approximately $8,221,058.34. This represents a 17.01% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 0.62% of the company's stock.

Synopsys Company Profile

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.